With the development of ADC approach, PBD has been used as a payload associated with specific antibodies in the treatment of different diseases, limiting the high toxicity associated with this molecule
The molar mass is 1419.53 g/mol and the CAS number is 137525-51-0
Compound movements (squats, deadlifts, rows, presses) for 3 sets of 8 to 12 reps twice a week is enough
Phase 2 cagrilintide alone ~10.8% body weight reduction at 26 weeks (4.5mg) Phase 2 CagriSema combo ~15.6% body weight reduction at 32 weeks Phase 3 REDEFINE 1 ~22.7% body weight reduction at 68 weeks Phase 2 CagriSema combination trial The Phase 2 trial of CagriSema was published in The Lancet in 2023, and its results attracted immediate attention
The same protocol that produces dramatic results for one researcher may show modest effects for another
It is important to distinguish the two compounds clearly: BPC-157 is not a fragment of TB4, and the two share no sequence homology